Google VC eyes biotech in data analytics push

Google Ventures, the venture firm backed by Google ($GOOG), is boosting its internal expertise in data analytics, and it views the life sciences industry as needing Big Data technology to solve some of its sticky research problems. In a sign the web giant's VC group wants to deepen its presence in the growing Big Data field, the firm has recently brought on Hazem Adam Ghobarah, who previously worked on quantitative research and modeling at Google, The New York Times reported. And Ghobarah has his eyes on opportunities in biology. "We keep coming back to life sciences" as an investment field, Ghobarah said, as quoted by the NYT. "In a given year, you have 200 million pathology slides. If that gets online, it is a Big Data problem." Item

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.